Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Senseonics Holdings (NY: SENS )

0.3397 +0.0014 (+0.41%)
Official Closing Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Senseonics Holdings

< Previous 1 2 3 4 5 6 7 8 Next >
Senseonics Shorts Get Burned And Options Traders Fan The Flames
Senseonics Holdings Inc. (NYSE: SENS) was trading up over 47% Friday afternoon on massive bullish volume. By midafternoon over 157 million shares of Senseonics had changed hands... 
Via Benzinga
Most Active Equity Options For Midday - Friday, June 4
Top tickers for midday: AMC, TSLA, AAPL, F, NVDA, BB, SNDL, PLTR, MSFT, WKHS, FB, NOK, NIO, SENS, BAC, SQ, AMZN, AMD, TLRY, RBLX. 
Via Talk Markets
Mid-Day Market Update: Gold Rises Over 1%; Harpoon Therapeutics Shares Plummet
Midway through trading Friday, the Dow traded up 0.39% to 34,713.33 while the NASDAQ rose 1.28% to 13,789.21. The S&P also rose, gaining 0.69% to 4,221.95. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
40 Stocks Moving In Friday's Mid-Day Session
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares jumped 68.8% to $25.49 after gaining 23% on Thursday. Senseonics Holdings, Inc. (NYSE: SENS) gained 26% to $2.5817 after the... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; US Economy Adds 559,000 Jobs in May
Following the market opening Friday, the Dow traded up 0.26% to 34,666.18 while the NASDAQ rose 1.22% to 13,780.27. The S&P also rose, gaining 0.64% to 4,219.82. The U.S. has... 
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
24 Stocks Moving in Friday's Pre-Market Session
Gainers Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM... 
Via Benzinga
10 Stocks Moving In Thursday's After-Hours Session
Gainers Five Below (NASDAQ: FIVE) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results and issued Q2 EPS and sales guidance... 
Via Benzinga
Why Senseonics Shares Are Rocketing Higher After Hours Thursday
Study results from a glucose monitoring company were reported after market close Thursday. What Happened: Medical technology company Senseonics Holdings (NYSE: SENS) reported... 
Via Benzinga
Senseonics Announces Results of the PROMISE Study Demonstrating Strong Accuracy of 180 Day CGM Sensor
From Senseonics Holdings, Inc.
Via Business Wire
10 Current And Former Penny Stocks With High Short Interest As BB & GME Stock Attract More Reddit Interest
Reddit stocks have surged thanks to big moves in BB and GME. With short interest as the focus, here are a few penny stocks to watch right now. 
Via Talk Markets
Revenue Boost and Cost Cutting Make the Case for Senseonics
SENS stock is undoubtedly volatile. Yet the long-term fiscal picture looks strong as Senseonics commercializes its lead product. 
Via InvestorPlace
This Significant New Partnership Makes Senseonics Stock Worth Another Look
SENS stock has much stronger fundamentals than your average penny stock. This diabetes care firm could rally again in coming months. 
Via InvestorPlace
Senseonics Vs. Novo Nordisk: Which Diabetes Stock Is A Better Buy?
Senseonics Holdings, Inc. and Novo Nordisk A/S are two established players in the medical industry. 
Via Talk Markets
If You Do the Math, Senseonics Makes No Sense
While the underlying science for SENS stock may be a game changer, ultimately, the market does not have the same sentiment. 
Via InvestorPlace
Senseonics Holdings, Inc. Reports First Quarter 2021 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings Has a Legitimate Chance in a Burgeoning Market
SENS stock is worth following in the growth sector of diabetes management devices and has growth ahead almost certainly. 
Via InvestorPlace
Advantage the Drift in Senseonics Stock Before It Recovers on FDA Nod
Take advantage of the drift in Senseonics before it recovers with a nod by the FDA nod. SENS stock will skyrocket after FDA approval. 
Via InvestorPlace
Exposures Product Safety
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
Why Senseonics Is An Intriguing Speculative Buy At These Levels
As far as speculative picks go, SENS stock is an intriguing option for investors looking for a speculative small cap play right now. 
Via InvestorPlace
Senseonics Holdings, Inc. Schedules First Quarter 2021 Earnings Release and Conference Call for May 13, 2021 at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings Is a Worthy Niche Diabetes-Care Investment
You might never have considered investing in a glucose monitoring company, but SENS stock is a good name to consider for health-care investors. 
Via InvestorPlace
Can This Popular Reddit Stock Make You Rich?
Up over 250% in less than a year, what's behind the rise of this hot stock? 
Via The Motley Fool
Mulling Senseonics Holdings? Beware What Lurks On Its Balance Sheet
Senseonics develops glucose monitoring products. Thanks to Reddit, SENS stock is up 111% year-to-date. Here’s why you shouldn’t buy. 
Via InvestorPlace
Biotechs Aligning to Address Challenges for Developing Therapeutics for Billion Dollar Neurological Disorders Industry
Via FinancialNewsMedia
Exposures COVID-19
20 Stocks Moving in Thursday's Pre-Market Session
Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:... 
Via Benzinga
Senseonics Stock Will Likely Rise on the Same Trajectory As DexCom
Senseonics will rise on the same trajectory as DexCom. SENS stock could rise 5 to 10 times over the next 5 years with FDA approval. 
Via InvestorPlace
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.